New method of treating cardiac autonomic neuropathy in patients with diabetes mellitus type 2

Cardiac autonomic neuropathy (CAN) is a common complication of diabetes mellitus. CAN has been associated with a poor prognosis in patients with diabetes mellitus, has been found to be a precursor for Sudden Cardiac Death and several other serious heart diseases. The next aim was to assess the heart rate variability (HRV) changes and discuss potential new treatment interventions by mildronat.